Understanding the roles of synovitis, knee-adjacent obesity and sarcopenia in pain phenotypes and structural progression of knee osteoarthritis - an analysis of the entire osteoarthritis initiative
Active Grant Awarded
- Award ID
- R56AR085666
- Recipient
-
The Regents Of The University Of California. San Francisco UEI KMH5K9V7S518
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $620,656
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date 18% complete
- Place of performance
- San Francisco, CA 94107, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services' National Institutes of Health awarded The Regents of the University of California, San Francisco a grant totaling $620,656 on September 23, 2026, under Assistance Listing 93.846, Arthritis, Musculoskeletal and Skin Diseases Research. The award is administered through the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
The funded work, Grant R56AR085666, analyzes the entire Osteoarthritis Initiative to determine how synovitis, knee-adjacent obesity, and sarcopenia relate to pain phenotypes and structural progression of knee osteoarthritis. The project measures modifiable risk factors fully automatically on MRI studies using machine learning algorithms, examines how mediators such as weight change, co-morbidities, mental health, diet, and physical activity affect outcomes, and develops clinically applicable machine learning models to predict pain and structural outcomes. The source describes three specific aims, but its text is truncated after Specific Aim 1, which investigates associations of modifiable risk factors with outcomes.
The full obligated amount is $620,656. The period of performance runs from the September 23, 2026 award date to an ultimate completion date of August 31, 2027. Place of performance is San Francisco, California 94107. The source identifies no sub-recipients.
Description
- Abstract
- Osteoarthritis (OA) is a highly prevalent joint disease affecting over 500 million individuals globally, of whom more than 260 million have knee OA. Obesity, inflammation, and sarcopenia are established modifiable risk factors for OA, and OA and other obesity-related diseases place an enormous physical and financial burden on the US healthcare system. Given our aging population and an associated increase in obesity, these numbers are expected to increase, leading to even higher rates of disability and healthcare costs. Obesity has become a US "epidemic," and projections have suggested that 86.3% of adults in the united states will be overweight or obese by 2030. Our recent work has suggested a complex interrelationship between the modifiable risk factors obesity, sarcopenia, and inflammation, with weight loss increasing sarcopenia and increased inflammation being associated with obesity. There is also a knowledge GAP on how these risk factors impact pain and structural outcomes, which is crucial for managing OA and influencing quality of life and mobility. Moreover, there is limited knowledge of how concurrent factors such as weight change, CO-morbidities, mental health, lifestyle (such as diet), and physical activity mediate the progression of osteoarthritis. The innovation of this proposal is centered on three key features: (I) modifiable risk factors that can be measured fully automatically on MRI studies with machine learning algorithms, (II) impact of mediators on OA outcomes including novel pain phenotype and structural outcomes, and (III) the development of clinically applicable machine learning models to predict pain and structural outcomes. Three specific aims are proposed: in specific aim 1, we will investigate the associations of modifiable risk factors synovitis, knee-adjacent obesity, and muscle volume and FAT infiltration with novel pain phenotypes and knee structural disease severity at baseline. In specific aim 2, we will analyze how longitudinal changes in synovitis, knee-adjacent obesity, and muscle impact outcomes of knee pain and structural changes. We will also conduct a mediation/pathway analysis to determine how this relationship is affected by weight change, CO- morbidities, lifestyle factors, and physical activity. We believe that these mechanisms/mediators being investigated are related to pain phenotypes and structural outcomes and that they may provide avenues to prevent the progression of OA. In specific aim 3, we will develop a clinically applicable prediction model using machine learning to determine which combination of modifiable biomarkers, demographic, and clinical features best predicts pain and structural outcomes in individuals with risk factors for or mild to moderate OA. The overall goal of this proposal is that by determining biological mechanisms and pathways responsible for OA-related outcomes such as pain (specific pain phenotypes and overall pain) and structural outcomes (based on radiographs and MRI findings) we will be able to identify potential treatment targets that prevent incidence and progression of knee OA.
Quick answers
Who received award R56AR085666?
R56AR085666 was awarded to The Regents Of The University Of California. San Francisco by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 23, 2026.
How much is award R56AR085666 worth?
$620,656 has been obligated on R56AR085666.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award